On July 9, Alnylam Pharmaceuticals rose 5.1% overnight, trading at $340.0 USD/share, with Turnover of $1.0826 million.
Within the Biotechnology sector where Alnylam Pharmaceuticals belongs, the overall sector showed muted performance. Among individual stocks, AbbVie up 0.0%, Vertex Pharmaceuticals up 0.18%, Gilead Sciences down 0.23%, Amgen down 0.19%, Regeneron Pharmaceuticals up 0%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)